413 related articles for article (PubMed ID: 23839077)
81. Trends in prognostic factors of melanoma in South Australia, 1981-1992: implications for health promotion.
Roder DM; Luke CG; McCaul KA; Esterman AJ
Med J Aust; 1995 Jan; 162(1):25-9. PubMed ID: 7845294
[TBL] [Abstract][Full Text] [Related]
82. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.
Koh HK; Norton LA; Geller AC; Sun T; Rigel DS; Miller DR; Sikes RG; Vigeland K; Bachenberg EU; Menon PA; Billon SF; Goldberg G; Scarborough DA; Ramsdell WM; Muscarella VA; Lew RA
J Am Acad Dermatol; 1996 Jun; 34(6):971-8. PubMed ID: 8647990
[TBL] [Abstract][Full Text] [Related]
83. A clinicopathological correlation of 134 stage 1 and 79 non-invasive cutaneous melanomas presenting over a decade (1984-1993) at the Mater Misericordiae Hospital, Dublin.
O'Donnell B; Dervan P; Codd M; Powell F; Lawlor D; O'Loughlin S
Ir J Med Sci; 1998; 167(3):132-5. PubMed ID: 9780558
[TBL] [Abstract][Full Text] [Related]
84. Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.
Youlden DR; Baade PD; Soyer HP; Youl PH; Kimlin MG; Aitken JF; Green AC; Khosrotehrani K
J Invest Dermatol; 2016 Nov; 136(11):2270-2276. PubMed ID: 27019458
[TBL] [Abstract][Full Text] [Related]
85. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe.
Garbe C; McLeod GR; Buettner PG
Cancer; 2000 Sep; 89(6):1269-78. PubMed ID: 11002222
[TBL] [Abstract][Full Text] [Related]
86. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
Hübner J; Waldmann A; Geller AC; Weinstock MA; Eisemann N; Noftz M; Bertram S; Nolte S; Volkmer B; Greinert R; Breitbart E; Katalinic A
Br J Cancer; 2017 Jan; 116(2):253-259. PubMed ID: 27898656
[TBL] [Abstract][Full Text] [Related]
87. Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage.
Vranova J; Arenbergerova M; Arenberger P; Vrana A; Zivcak J; Kolarova H; Rosina J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):438-46. PubMed ID: 23128825
[TBL] [Abstract][Full Text] [Related]
88. Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.
Pizzichetta MA; Massi D; Mandalà M; Queirolo P; Stanganelli I; De Giorgi V; Ghigliotti G; Cavicchini S; Quaglino P; Corradin MT; Rubegni P; Alaibac M; Astorino S; Ayala F; Magi S; Mazzoni L; Manganoni MA; Talamini R; Serraino D; Palmieri G;
J Transl Med; 2017 Nov; 15(1):227. PubMed ID: 29115977
[TBL] [Abstract][Full Text] [Related]
89. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
[TBL] [Abstract][Full Text] [Related]
90. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
Katalinic A; Eisemann N; Waldmann A
Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
[TBL] [Abstract][Full Text] [Related]
91. Cutaneous malignant melanoma in Australia, 1989.
Jelfs PL; Giles G; Shugg D; Coates M; Durling G; Fitzgerald P; Ring I
Med J Aust; 1994 Aug; 161(3):182-7. PubMed ID: 8035720
[TBL] [Abstract][Full Text] [Related]
92. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
Landow SM; Gjelsvik A; Weinstock MA
J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
[TBL] [Abstract][Full Text] [Related]
93. Incidence and mortality data from cutaneous melanoma in Trentino: registry-based study.
Boi S; Cristofolini M; Micciolo R; Polla E; Piffer S; Gentilini M
J Cutan Med Surg; 2008; 12(2):59-63. PubMed ID: 18346401
[TBL] [Abstract][Full Text] [Related]
94. Superficial spreading melanoma: an analysis of 97 702 cases using the SEER database.
Singh P; Kim HJ; Schwartz RA
Melanoma Res; 2016 Aug; 26(4):395-400. PubMed ID: 26926150
[TBL] [Abstract][Full Text] [Related]
95. Incidence of cutaneous malignant melanoma in the Ottawa region: 1996 to 2006.
Nevins T; Su Y; Doucette S; Kanigsberg N
J Cutan Med Surg; 2008; 12(6):276-81. PubMed ID: 19317949
[TBL] [Abstract][Full Text] [Related]
96. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
Lo SN; Scolyer RA; Thompson JF
Ann Surg Oncol; 2018 Apr; 25(4):894-902. PubMed ID: 29330716
[TBL] [Abstract][Full Text] [Related]
97. Clinicopathologic features of primary cutaneous melanoma: a single centre analysis of a Swiss regional population.
Heppt MV; Reinholz M; Tietze JK; Kerl K; French LE; Berking C; Kamarashev J
Eur J Dermatol; 2015 Apr; 25(2):127-32. PubMed ID: 25787976
[TBL] [Abstract][Full Text] [Related]
98. The prognostic significance of ulceration of cutaneous melanoma.
Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
[TBL] [Abstract][Full Text] [Related]
99. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
[TBL] [Abstract][Full Text] [Related]
100. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.
MacKie R; Hunter JA; Aitchison TC; Hole D; Mclaren K; Rankin R; Blessing K; Evans AT; Hutcheon AW; Jones DH
Lancet; 1992 Apr; 339(8799):971-5. PubMed ID: 1348807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
